3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Burkitt Lymphoma
20
Neoplasm, Residual
9
Leukemia
6
Lymphoproliferative Disorders
4
Lymphoma, Non-Hodgkin
4
Lymphatic Diseases
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Lymphoid
3
Recurrence
2
Myelodysplastic Syndromes
2
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Immunoproliferative Disorders
2
Blast Crisis
2
Sarcoma, Myeloid
1
Philadelphia-Negative ALL
1
Philadelphia Chromosome
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Down Syndrome
1
Interventions
Imatinib Mesylate
8
Dasatinib
4
Vincristine
3
Methotrexate
3
Dexamethasone
3
Cytarabine
3
peginterferon alfa-2a
2
Prednisone
2
Daunorubicin
2
Cyclophosphamide
2
venetoclax
1
ponatinib
1
olverembatinib
1
flumatinib
1
bosutinib
1
blinatumomab
1
Prednisolone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mitoxantrone
1
Mercaptopurine
1
Interferons
1
Inotuzumab Ozogamicin
1
Etoposide
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Philadelphia Chromosome
×
blinatumomab
×
Clear all
NCT06220487
2024-01-24
ABC
Nanfang Hospital, Southern Medical University
Phase 2
Recruiting
67 enrolled